Pediatrix Medical Group (MD) Q2 FY26 earnings call

Pediatrix Medical Group delivered a solid second quarter, meeting expectations with strong adjusted EBITDA and reaffirming its full-year outlook. The company continues to leverage its financial strength for share repurchases and strategic growth opportunities in women's and children's medicine, including telehybrid services. While facing slight volume declines, favorable pricing dynamics from RCM collections, payer mix, and acuity offset these pressures.